Brief: An2 Therapeutics Reports Third Quarter 2022 Financial Results
09/11/2022 21:52
Nov 9 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* AN2 THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
TOTALED $106.4 MILLION ON SEPTEMBER 30, 2022
* AN2 THERAPEUTICS INC- QTRLY NET LOSS PER SHARE
ATTRIBUTABLE TO
COMMON STOCKHOLDERS, BASIC AND DILUTED $0.59
Source text for Eikon: ID:nGNX9f2zt1
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview